Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
2.800
+0.050 (1.82%)
Nov 22, 2024, 4:00 PM EST - Market closed
Relmada Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Hold
Price Target
$7.50
Upside
+167.86%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $3.5 → $13 | Hold → Strong Buy | Upgrades | $3.5 → $13 | +364.29% | Sep 17, 2024 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $3 → $2 | Hold → Strong Sell | Downgrades | $3 → $2 | -28.57% | Jun 5, 2024 |
| Mizuho | Mizuho | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +828.57% | Jun 15, 2023 |
| SVB Leerink | SVB Leerink | Buy Maintains $42 → $10 | Buy | Maintains | $42 → $10 | +257.14% | Jan 23, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $8 | Strong Buy → Hold | Downgrades | $8 | +185.71% | Oct 14, 2022 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 14, 2022 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 13, 2022 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $49 → $81 | Strong Buy | Maintains | $49 → $81 | +2,792.86% | Sep 23, 2022 |
| Guggenheim | Guggenheim | Strong Buy Maintains $50 → $60 | Strong Buy | Maintains | $50 → $60 | +2,042.86% | Sep 6, 2022 |
| Oppenheimer | Oppenheimer | Buy Maintains $75 → $64 | Buy | Maintains | $75 → $64 | +2,185.71% | May 9, 2022 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $69 → $53 | Strong Buy | Maintains | $69 → $53 | +1,792.86% | Mar 24, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains $50 → $42 | Buy | Maintains | $50 → $42 | +1,400.00% | Dec 20, 2021 |
| Mizuho | Mizuho | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +1,685.71% | Nov 18, 2021 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $69 → $40 | Strong Buy → Hold | Downgrades | $69 → $40 | +1,328.57% | Oct 28, 2020 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $63 | Strong Buy | Initiates | $63 | +2,150.00% | Apr 21, 2020 |
| Jefferies | Jefferies | Strong Buy Initiates $75 | Strong Buy | Initiates | $75 | +2,578.57% | Jan 27, 2020 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.